⌘+K

February 13, 2023The Lancet OncologyOpen Access

Prognostic implications of p16 and HPV discordance in oropharyngeal cancer (HNCIG-EPIC-OPC): a multicentre, multinational, individual patient data analysis

View Full Paper

Ask AI

Bookmark

Share

Ask about this paper

Answers are grounded in this paper and cite their sources.

Abstract

European Regional Development Fund, Generalitat de Catalunya, National Institute for Health Research (NIHR) UK, Cancer Research UK, Medical Research Council UK, and The Swedish Cancer Foundation and the Stockholm Cancer Society.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Mehanna et al. (2023) studied this question.

synapsesocial.com/papers/69d76424086f9d6299f30d57 https://doi.org/10.1016/s1470-2045(23)00013-x

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 10 related papers. Consider them for comparative context:

1Prevalence of human papillomavirus in oropharyngeal and nonoropharyngeal head and neck cancer—systematic review and meta‐analysis of trends by time and regionMeta-Analysis · 2012 · 883 citations
2A Contemporary Systematic Review on Repartition of HPV-Positivity in Oropharyngeal Cancer WorldwidePrognostic Study · 2021 · 127 citations
3Incidence of human papillomavirus (HPV) positive tonsillar carcinoma in Stockholm, Sweden: An epidemic of viral‐induced carcinoma?Original Research · 2009 · 731 citations
4Worldwide Trends in Incidence Rates for Oral Cavity and Oropharyngeal CancersRegistry Study · 2013 · 1,315 citations
5Human Papillomavirus and Survival of Patients with Oropharyngeal CancerPrognostic Study · 2010 · 6,578 citations
6Radiotherapy plus cisplatin or cetuximab in low-risk human papillomavirus-positive oropharyngeal cancer (De-ESCALaTE HPV): an open-label randomised controlled phase 3 trialRisk Assessment · 2018 · 1,054 citations
7Tumor suppressor p16 <sup>INK4A</sup> is necessary for survival of cervical carcinoma cell linesOriginal Research · 2013 · 172 citations
8Correlation between human papillomavirus and p16 overexpression in oropharyngeal tumours: a systematic reviewPrognostic Study · 2014 · 217 citations
9Zamtocabtagene autoleucel, a tandem CD20–CD19-directed CAR T-cell therapy, for second line treatment of large B-cell lymphoma in patients ineligible for transplantation (DALY 2-EU): primary analysis of an open-label, multicentre, randomised phase 2 studyThe Lancet Oncology · 2026
10Global burden of cancer attributable to infections in 2024: a worldwide incidence analysisThe Lancet Oncology · 2026

More from The Lancet Oncology

More from University of Toronto